Yesterday (April 2), US President Donald Trump announced sweeping new tariffs targeting nearly all US trading partners. The policy includes a 10% baseline tariff on all imported goods and country-specific “reciprocal” tariffs of up to 50% that target nations with perceived unfair trade barriers against US products. Key trading partners such as the EU, Japan, […]
April 2025
The initial months of 2025 have been extraordinary for higher education. Colleges and universities are facing questions about their missions, policies, curricula, and why they have endowments. While endowment wealth is in the headlines and crosshairs, the purpose of endowments can be lost, under the radar one might say. The 2024 Endowment Radar Study highlights […]
March 2025
Yes, in response to weak growth and a changing defence landscape, taking off the fiscal straitjacket should catalyse a more growth-supportive economic environment within Europe. There will be a direct growth impact as increased government investment is disbursed, some crowding in of private-sector investment, and the potential for further positive growth benefits from subsequent institutional […]
March 2025
Over the last few decades, many not-for-profit healthcare systems have enjoyed strong margins driven by favorable demographic trends, inexpensive debt, and improved cost structures through mergers & acquisitions. As a result, many of those systems have been able to amass significant investable reserves. However, in many cases the purpose of the investment portfolio is often […]
March 2025
In the first half of 2024, returns from US private equity and venture capital (PE/VC) were modest; the Cambridge Associates LLC US Private Equity Index® earned 3.4% and the Cambridge Associates LLC US Venture Capital Index® earned 1.4%. Within PE, buyouts and growth equity posted similar results (3.3% and 3.6%, respectively), but PE/VC returns generally […]
March 2025
No, investors should hold equity allocations in line with their policy portfolio weights. Trade policy uncertainty has forced many investors to reassess the trajectory of global economic growth, sending ripples through markets, and prompting US equities to enter a “correction” on March 13. Still, there are strong arguments for holding equity allocations steady. For instance, […]
March 2025
No, we do not think so. India’s economic growth is set to continue moderating, which may lead to further downgrades to stretched earnings growth expectations. Current equity valuations remain elevated, which poses additional downside risk. Still, the recent correction has taken some froth out of the market, and India’s longer-term structural tailwinds remain intact. As […]
March 2025
No, we don’t think so. There are parallels between today’s AI-related developments and the internet revolution of the late 1990s and early 2000s, as both eras involve profound technological change. Market concentration, increased capital investments, and valuation risks are among those parallels. However, the quality of companies today is higher and speculative excesses are less […]
February 2025
If you satisfy any of these criteria, please click confirm to proceed:
*As defined in the Markets in Financial Instruments Directive (Directive 2014/65/EC) as amended or updated (MiFID)
If you satisfy any of these criteria, please click confirm to proceed:
*An entity regulated by its local country regulator which may include banks, collective investment schemes, endowments, foundations, investment managers, insurance companies, pension funds and intermediaries
The information contained herein is not suitable for retail investors.
Please contact us if you have any questions: ContactCA@cambridgeassociates.com
If you clicked decline in error, please click here